AM-5262 is a potent and selective full agonist of the GPR40 receptor, exhibiting an improved pharmacokinetic profile in rats. This compound is a valuable research tool for investigating GPR40's role in metabolic diseases, supporting both in vitro binding assays and in vivo studies related to insulin secretion and glucose homeostasis.